News Digging > Podcasts > Amylyx’s ALS drug launch starts strong. That could be trouble for the FDA
Amylyx’s ALS drug launch starts strong. That could be trouble for the FDA
Amylyx's ALS drug launch starts strong. That could be trouble for the FDA,Behind the stellar launch of Amylyx Pharmaceuticals’ treatment for ALS lies an uncomfortable question: Does early success of the drug make it more complicated to pull it from the market if we find out next year that it doesn’t work?

Amylyx’s ALS drug launch starts strong. That could be trouble for the FDA

The FDA could face a quandary if an ongoing and larger clinical trial shows ALS patients aren’t benefiting from the drug.